vancomycin has been researched along with B cepacia Infection in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kopell, BH; Rasouli, JJ | 1 |
| Das, T; Joseph, J; Pathengay, A; Sachdeva, V; Sharma, S | 1 |
| Matoba, AY | 1 |
| Baltimore, RS; Beardsley, DS; Begier, EM; Browne, FA; Dembry, LM; Hadler, JL; Held, MR; Jensen, B; Martinello, RA; McDonald, LC | 1 |
4 other study(ies) available for vancomycin and B cepacia Infection
| Article | Year |
|---|---|
The Adjunctive Use of Vancomycin Powder Appears Safe and May Reduce the Incidence of Surgical-Site Infections After Deep Brain Stimulation Surgery.
Topics: Administration, Topical; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Burkholderia cepacia; Burkholderia Infections; Cefuroxime; Deep Brain Stimulation; Device Removal; Doxycycline; Dystonia; Humans; Incidence; Intraoperative Care; Male; Middle Aged; Neurosurgical Procedures; Parkinson Disease; Powders; Prosthesis Implantation; Prosthesis-Related Infections; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Surgical Wound Infection; Vancomycin | 2016 |
Burkholderia cepacia endophthalmitis: clinico-microbiologic profile and outcomes.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Burkholderia cepacia; Burkholderia Infections; Ceftazidime; Child; Endophthalmitis; Eye Infections, Bacterial; Eye Injuries; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Postoperative Complications; Retrospective Studies; Treatment Outcome; Vancomycin; Visual Acuity | 2011 |
Polymicrobial keratitis secondary to Burkholderia ambifaria, enterococcus, and staphylococcus aureus in a patient with herpetic stromal keratitis.
Topics: Amikacin; Burkholderia; Burkholderia Infections; Corneal Stroma; Drug Therapy, Combination; Enterococcus; Eye Infections, Bacterial; Gram-Positive Bacterial Infections; Humans; Keratitis, Herpetic; Levofloxacin; Male; Middle Aged; Ofloxacin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2003 |
Life-threatening sepsis caused by Burkholderia cepacia from contaminated intravenous flush solutions prepared by a compounding pharmacy in another state.
Topics: Bacteremia; Burkholderia cepacia; Burkholderia Infections; Catheterization, Central Venous; Child; Child, Preschool; Disease Notification; Drug Compounding; Drug Contamination; Electrophoresis, Gel, Pulsed-Field; Equipment Contamination; Factor VIII; Heparin; Humans; Infusions, Intravenous; Male; Vancomycin | 2006 |